News & analysis on the clinical development and manufacture of large molecule drugs
Hired and Retired: Transitions at the top
By Ben Hargreaves
- Last updated on
In a significant move at the larger end of the biopharma world, AstraZeneca’s global VP of cardiovascular, renal and metabolism made the move to Novo Nordisk to head up its biopharm unit.
Another move saw a boost to the number of women working in leadership positions in the biopharma industry, with the appointment of Vanessa King and Isabel Najera at newly formed biotech, Virion Biotherapeutics.
For these appointments and more, click through the gallery: